Labcorp and Quest Diagnostics urge Congress to pass the RESULTS Act by year-end to prevent Medicare and Medicaid reimbursement cuts beginning in 2027, highlight

The FDA clears a device to fix leaky heart valves, treating paravalvular leak after valve replacement surgery.

Boston Scientific slashes 2026 earnings and sales guidance for the third consecutive time due to a cyberattack and product line challenges, lowering revenue gro

AI adoption in medtech is more complicated than many expect, with leaders at AdvaMed’s conference warning that deployments are far fewer than hype suggests.

MedTech CEOs in Boston discuss cybersecurity threats and cost pressures at AdvaMed conference, sharing strategies for navigating market challenges in the medica

Edwards Lifesciences receives FDA clearance for tricuspid valve repair device to treat severe symptomatic tricuspid regurgitation.

FDA expands import block, halting shipment of five Olympus endoscopes made in Japan after a June 2025 alert barred 58 devices over patient safety concerns.

Health providers argue developers should be accountable for safety of medical devices using generative artificial intelligence, not them, in recent comments to

Labcorp Myriad prenatal testing acquisition for $210M expands diagnostic capabilities with four key tests projected to generate $160M annually.

Intuitive’s U.S. robotic-surgery growth slowed to 10% in Q3 2025, marking the weakest pace since COVID-19, as CEO David Rosa shifts focus to broader adoption.